Search & Analyze

Q-Line Biotech Ltd.

512.750.00 (0.00%)

NSE

: ₹1,196.15 Cr
: 21.47
: —
: —
: —

Q-Line Biotech Ltd. (QLINE) share price closed at ₹512.75 on the NSE.

Stock Overview

Key Fundamentals

: 1,196.15 Cr₹1.20 Thousand Crore
: 23.89
: 21.47
: 4.72
: 108.56
: 103.80 Cr₹103.80 Crore
: 0.00 %
Sector
Industry: Medical Equipment/Supplies/Accessories
: 25.55
: 0.92

Industry Comparison

Ratio	Company	Sector
	21.47	44.77
	0.92	0.20
	4.72	4.61
	1.64	1.81
	0.00 %	0.11 %
Operating Margin	27.13 %	19.15 %

Sector figures are the median of 154 listed Healthcare companies.

Peer Comparison

Name
LENSKART LENSKART	678.20	179.99	1,17,959.74	0.00	228.43	273.43%	2,714.18	43.27%	12.55
MOLBIO MOLBIO	1,274.65	88.17	14,689.07	0.00	52.74	320.28%	408.38	309.57%	19.79
POLY MEDICUR POLYMED	1,447.80	46.58	14,675.11	0.24	85.27	-8.39%	525.38	30.30%	14.05
SMT SMT	459.95	71.61	4,675.24	0.00					11.93
Q-Line Biotech Ltd. QLINE	512.75	21.47	1,196.15	0.00					22.23
3BBLACKBIO 3BBLACKBIO	1,298.95	20.04	1,114.85	0.39	8.98	-28.99%	33.49	50.62%	25.90
LAXMIDENTL LAXMIDENTL	177.80	31.67	978.42	0.00	10.32	23.83%	74.70	13.87%	13.29
GKB OPHTHA GKB	59.00	9.06	29.74	0.00	1.85	387.99%	33.04	2.28%	8.82

Quarterly Results

consolidated figures in ₹ Crores · Quarterly

Particulars

Profit & Loss

consolidated figures in ₹ Crores · Annual

Particulars	FY 2022-23 (Mar)	FY 2023-24 (Mar)	FY 2024-25 (Mar)	FY 2025-26 (Mar)
No of Months	12.00	12.00	12.00	12.00
INCOME :
	182.74	203.65	313.14	361.52
	182.74	203.65	313.14	341.74
EXPENDITURE :
Increase/Decrease in Stock	-4.49	-28.01	30.66	-3.37
Raw Material Consumed	92.95	121.03	115.62	137.48
Power & Fuel Cost	0.56	0.84	1.62	1.43
Employee Cost	18.88	20.52	27.18	35.19
Other Manufacturing Expenses	15.12	26.97	33.91	32.22
General and Administration Expenses	19.14	19.68	20.48	26.57
Selling and Distribution Expenses	4.28	1.65	1.51	1.43
Miscellaneous Expenses	2.53	2.90	20.52	12.70
	148.99	165.58	251.50	243.64
Operating Profit (Excl OI)	33.75	38.06	61.64	98.10
	2.08	2.80	12.08	5.70
	35.83	40.86	73.72	103.80
Interest	3.85	6.34	14.97	19.47
PBDT	31.98	34.53	58.74	84.33
	2.14	3.93	7.03	10.79
Profit Before Taxation & Exceptional Items	29.84	30.60	51.71	73.54
Exceptional Income / Expenses			-16.97	-0.99
	29.84	30.60	34.74	72.55
Provision for Tax	8.46	8.96	19.06	16.83
	21.38	21.64	15.68	55.72
Extra items	0.00	0.00	0.00	0.00
Minority Interest		0.00
Share of Associate	10.71	12.80	3.53
Consolidated Net Profit	32.10	34.45	19.21	55.72
Profit Balance B/F	92.39	124.49	167.77	187.08
Appropriations	124.49	158.94	186.98	242.80
	203.79	218.73	121.98	34.24
Adjusted EPS	20.38	21.87	12.20	34.24

Balance Sheet

consolidated figures in ₹ Crores

Particulars	FY 2022-23 (Mar)	FY 2023-24 (Mar)	FY 2024-25 (Mar)	FY 2025-26 (Mar)
	1.58	1.58	1.58	16.28
Total Reserves	125.79	160.24	188.38	229.92
Reserve excluding Revaluation Reserve	125.79	160.24	188.38	229.92
Revaluation reserve	0.00	0.00
	127.37	161.81	189.95	246.19
Secured Loans	10.39	32.29	82.19	89.62
Unsecured Loans	3.91	2.80	0.22	6.57
Deferred Tax Assets / Liabilities	-0.71	-0.58	-0.98	-1.06
Other Long Term Liabilities	0.10	0.20	1.37	1.99
Long Term Provisions	1.66	1.86	2.62	4.39
Total Non-Current Liabilities	15.36	36.58	85.42	101.51
Trade Payables	39.71	59.24	55.62	52.04
Other Current Liabilities	11.30	28.06	52.06	62.16
Short Term Borrowings	54.17	50.40	55.46	89.61
Short Term Provisions	2.97	2.58	16.00	6.10
Total Current Liabilities	108.15	140.28	179.14	209.92
Total Liabilities	250.87	338.67	454.51	557.62
Gross Block	31.61	72.66	92.93	171.94
Less: Accumulated Depreciation	8.81	12.73	19.28	30.37
	22.80	59.92	73.64	141.58
	11.74	19.17	59.03	15.40
Non Current Investments	15.70	28.51	17.95	16.67
Long Term Investment	15.70	28.51	17.95	16.67
Long Term Loans & Advances	10.71	14.84	11.29	15.14
Other Non Current Assets	13.81	17.69	24.44	20.87
Total Non-Current Assets	74.76	140.14	189.88	213.57
Inventories	43.59	105.24	90.21	94.96
Sundry Debtors	33.06	26.44	82.60	125.82
Cash and Bank	90.02	29.96	47.03	76.44
Other Current Assets	0.22	0.58	12.54	13.37
Short Term Loans and Advances	9.22	36.31	32.26	33.46
Total Current Assets	176.11	198.53	264.64	344.06
Net Current Assets (Including Current Investments)	67.96	58.25	85.50	134.14
Total Assets	250.87	338.67	454.51	557.62
			19.30	52.55
Total Debt	73.65	96.91	166.29	225.48
	808.67	1,027.39	1,206.06	151.27
Adjusted Book Value	80.87	102.74	120.61	151.27

Cash Flow

consolidated figures in ₹ Crores

Particulars	FY 2022-23 (Mar)	FY 2023-24 (Mar)	FY 2024-25 (Mar)	FY 2025-26 (Mar)
No of Months	12.00	12.00	12.00	12.00
	29.84	30.61	34.74	72.55
Adjustment	4.88	8.85	54.15	30.55
Changes In working Capital	2.68	-54.38	-63.28	-60.70
Cash Flow after changes in Working Capital	37.40	-14.92	25.61	42.40
Cash Flow from Operating Activities	24.97	-24.18	17.21	16.38
Cash Flow from Investing Activities	-26.31	-44.69	-77.47	-29.42
Cash Flow from Financing Activitie	26.40	16.99	53.18	41.64
Net Cash Inflow / Outflow	25.06	-51.88	-7.08	28.60
Opening Cash & Cash Equivalents	46.54	71.60	19.72	12.64
Closing Cash & Cash Equivalent	71.60	19.71	12.64	41.24

Ratios

Valuation

21.47

4.72

12.96

3.50

23.89

108.56

Profitability

25.55

22.23

11.01

27.13

15.41

Leverage & Liquidity

0.92

1.64

4.73

Returns

0.00

0.71

Shareholding Pattern

Numbers in percentages

Particulars	May '26	Sep '26
	67.51	67.51
	11.17	9.03
	21.32	23.45
	32.49	32.49
No. of Shareholders	3,497	2,948

Mutual Funds Invested(1)

Based on each fund's latest monthly portfolio · Sep 2026

A total of 1 active fund holds 2.20% in Q-Line Biotech Ltd., contributing to ₹35 Cr of holdings

Fund				As of
AB Abakkus Small Cap Fund - Growth - Direct PlanSmall cap Fund	34.98	1.08	5,13,600	Sep '26

Corporate Actions

Showing: All

Date	Type	Details
2026-09-05	AGM	Q-Line Biotech Limited has informed the Exchange regarding Outcome of Board Meeting held on September 05, 2026.
2026-09-04	Board Meeting	Other business matters
2026-06-12	Board Meeting	Financial Results/Other business matters

Insider Trading

Date	Person	Category	Transaction Type	Shares	Value (₹)

No insider trading data available.

Sector Overview

HealthcareMedical Equipment/Supplies/Accessories

Q-Line Biotech Ltd. operates in the Healthcare sector under the Medical Equipment/Supplies/Accessories industry. This sector is one of the key drivers of the Indian economy and is closely tracked by the relevant Nifty sectoral index.

Company Profile

Corporate information and contact details

Key Management

12 members across the board and senior leadership

Akhand Pratap Singh

Company Secretary & Compliance Officer

—

Saurabh Garg

Chairman & Managing Director

₹1.34 Cr

Mar '26

Kuldeep Chowdhry

Whole Time Director

₹72.99 L

Mar '26

Ajay Kumar Mahanty

Whole Time Director

₹99.60 L

Mar '26

Yethadka Subraya Prabhakara

Whole Time Director

₹27.03 L

Mar '26

Jai Prakash Singh

Non Executive Independent Director

—

Pravir Kumar

Non Executive Independent Director

—

Rohit Nandan

Non Executive Independent Director

—

Abhishek Mishra

Non Executive Independent Director

—

Abhay Agrawal

Promoter & Non-Executive Director

—

Amita Garg

Promoter & Non-Executive Director

—

Ayush Garg

Promoter & Non-Executive Director

₹1.61 Cr

Mar '26

QLINE Latest News

News

1 of 1 article

IPO20 May 2026 · 13:12

Q-Line Biotech coming with IPO to raise up to Rs 214.48 crore

The issue will open on May 21, 2026 and will close on May 25, 2026

Q-Line Biotech Ltd.

Stock Overview

Price chart

Peer Comparison

Quarterly Results

Profit & Loss

Balance Sheet

Cash Flow

Ratios

Valuation

Profitability

Leverage & Liquidity

Returns

Shareholding Pattern

Mutual Funds Invested(1)

Corporate Actions

Insider Trading

Sector Overview

Company Profile

Key Management

QLINE Latest News

News